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a b s t r a c t
Background: Evidence is limited regarding the role of mechanical circulatory support (MCS) in patients with
acute coronary syndromes (ACS) complicated by cardiogenic shock (CGS). In particular, the role of MCS in patients with out-of-hospital cardiac arrest (OHCA) is unknown.
Methods: The National Cardiogenic Shock Initiative (NCSI) is a multicenter United States registry of patients with
ACS complicated by CGS treated with MCS. We compared the rate of survival to hospital discharge among patients with OHCA, in-hospital cardiac arrest (IHCA), or no cardiac arrest. We subsequently used multivariable
analyses to determine independent predictors of OHCA survival.
Results: Survival to hospital discharge occurred in 85.7% (42/49) of OHCA, 72.4% (50/69) of IHCA, and 74.5% (111/
149) of non-cardiac arrest patients. By multivariable analysis, pre-procedural predictors of survival included
younger age, female sex, fewer diseased vessels, left anterior descending coronary artery culprit, lower troponin,
higher lactate, and delayed initiation of MCS. Procedural and post-procedural predictors of survival included
fewer vessels treated, complete revascularization, higher post-MCS cardiac power output, and fewer inotropic
medications required.
Conclusions: This study demonstrates that excellent outcomes may be achieved following OHCA when MCS is
employed for patients appropriately selected by prognostic demographic, anatomic, and health status characteristics. A larger study population, currently being enrolled, is needed to validate the observation further.
© 2020 Elsevier Inc. All rights reserved.

1. Introduction
Out-of-hospital cardiac arrest (OHCA) is a devastating event associated with poor outcomes. Non-traumatic OHCA is estimated to affect
347,322 adults per year in the United States with a dismal rate of only
11.4% survival to hospital discharge [1]. Coronary artery disease (CAD)
is strongly associated with OHCA, with CAD present in >70% of patients
resuscitated from OHCA [2]. Data from the Parisian Region Out of hospital Cardiac ArresT (PROCAT) Registry suggest that early angiography
⁎ Corresponding author at: Division of Cardiovascular Medicine, University of Nebraska
Medical Center, 982265 Nebraska Medical Center, Omaha, NE 68198, United States of
America.
E-mail address: andrew.goldsweig@unmc.edu (A.M. Goldsweig).

and percutaneous coronary intervention (PCI) improve survival in
OHCA, irrespective of the presence of ST elevation on electrocardiogram
(ECG) [3,4]. The 2015 American Heart Association guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care include a
Class I (level of evidence [LOE] B non-randomized [NR]) recommendation to perform emergent coronary angiography for patients with
OHCA of suspected cardiac etiology and ST elevation on ECG; for patients without ST elevation on ECG, emergent coronary angiography is
reasonable in select electrically or hemodynamically unstable patients,
even if they are comatose (class IIa, LOE B-NR) [5].
The National Cardiogenic Shock Initiative (NCSI) is a multicenter
study of patients presenting with acute coronary syndrome (ACS) complicated by cardiogenic shock (CGS). Per the single-arm NCSI protocol,
patients are treated with early initiation of mechanical circulatory
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support (MCS) with the Impella device (Abiomed, Danvers, MA) as well
as PCI. Interim results from 171 patients demonstrated 72% survival to
discharge [6], a signiﬁcant improvement over the historical survival
rate of 40% reported by the PROCAT Registry [3].
However, no study to date has examined the effect of MCS on OHCA
survival. Therefore, we undertook to study OHCA survival in the subset
of patients enrolled in NCSI who presented with OHCA. An understanding of the efﬁcacy of MCS following OHCA and predictors of survival will
allow for optimal use of MCS in strategies to maximize OHCA survival.
2. Methods
The NCSI protocol has been previously published [7]. Brieﬂy, NCSI
enrolls patients with ACS, deﬁned as non-ST-elevation myocardial infarction (NSTEMI) or STEMI, and CGS, deﬁned as the presence of at
least two of the following: hypotension (systolic blood pressure ≤ 90 mmHg, or inotropes/vasopressors to maintain systolic blood
pressure ≥ 90 mmHg), signs of end organ hypoperfusion (cool extremities, oliguria or anuria, or elevated lactate levels), or hemodynamic
criteria (cardiac index of <2.2 L/min/m2 or a cardiac power output
≤0.6 W). Data collected include demographics, admission characteristics, timings from presentation and shock to support and intracoronary
balloon inﬂation, coronary artery disease anatomy, hemodynamics,
medications, and survival.
We identiﬁed the cohort of NCSI patients who presented with OHCA,
deﬁned as the absence of a palpable pulse. For enrollment of OHCA patients, NCSI study criteria included witnessed arrest, <30 min of total
cardiopulmonary resuscitation (CPR), and no clinical evidence of anoxic
brain injury (seizure, posturing) upon initial presentation prior to MCS
or PCI.
As a primary outcome, we determined the rate of survival to discharge of OHCA patients treated per the NCSI protocol. We then compared this survival rate with in-hospital CA (IHCA, principally patients
who presented with ACS with CGS and arrested in the emergency department, in transport, or in the catheterization laboratory prior to
PCI) as well as with non-OHCA NCSI patients. As a secondary outcome,
we determined and quantiﬁed the variables that independently predicted increased OHCA survival in patients treated with MCS using multivariable analyses.

Fig. 1. Rates of survival to hospital discharge for NCSI patients with OHCA, IHCA, and no
cardiac arrest.

Average patient age was 65.4 years and 55.9 years among nonsurvivors and survivors, respectively, and survival rate was higher
among women (90.0%) than men (84.6%) (panels (A)–(C)). For diseased vessels, 85.7% of non-survivors and 61.9% of survivors had more
than one diseased vessel (panel (D)). The culprit lesion was in the
LAD in 19.0% percent of the survivors but none of the non-survivors.
Pre-Impella troponin (1.17 vs. 2.21 ng/dL) and pre-Impella lactate
(5.14 vs. 7.28 mmol/L) level were higher among survivors compared
to non-survivors (panels (E)–(G)).
By multivariable analysis, survivors had delayed MCS and PCI compared to non-survivors (Fig. 3). Average times for door to support
(92.2 ± 77.4 vs. 166.9 ± 369.8 min), onset of shock to support
(107.6 ± 73.0 vs. 230.6 ± 467.8 min), and door to balloon (92.8 ±
70.0 vs. 182.0 ± 369.8 min) were higher among the survivors compared
to the non-survivors. In addition, the variations in these times (measured in standard deviations) were greater among the survivors than
among the non-survivors for all three measurements.
MCS/PCI predictors of survival included fewer vessels treated, complete revascularization, higher post-Impella cardiac power output
(CPO), and few inotropes (Fig. 4). Compared to non-survivors, survivors
were less likely to have more than one treated vessel (42.8% vs. 38.1%),
while they were more likely to have complete revascularization (66.7%
vs. 75.0%) (panels (A)–(B)). The post-Impella CPO was 0.67 W among
non-survivors while 0.97 W among survivors (panel (C)). The average
number of post-Impella vasopressors/inotropes (i.e., total number of
norepinephrine, epinephrine, vasopressin, dobutamine, milrinone,
phenylephrine, and other vasopressors/inotropes) was lower among
the survivors (1.14 vs. 0.55).
Notably, at the present stage of on-going NCSI data collection, the
sample size remains small, so many of these preliminary results were
not statistically signiﬁcant by a p < 0.05 threshold.

3. Results
Among patients enrolled in NCSI, 49 had OHCA, and 85.7% of these
(42/49) survived to discharge. By contrast, among the 69 patients that
had IHCA (whether or not they also had OHCA), the rate of survival to
discharge was 72.5% (50/69) (Fig. 1). Of the 149 patients with no cardiac
arrest, the rate of survival to discharge was 74.5% (111/149). Society for
Cardiovascular Angiography and Interventions (SCAI) Shock Stage [8] at
the time of PCI was highest for the IHCA group, intermediate for the
OHCA group, and lowest for the group without cardiac arrest
(Table 1), although some SCAI Shock Stage data were missing, particularly in the group without cardiac arrest.
Due to the emergent nature of OHCA, patient presentation data were
limited. Data on bystander cardiopulmonary resuscitation (CPR) were
available for 32/49 patients: 23/32 received bystander CPR (survival to
discharge 20/23), and 9 did not receive bystander CPR (survival to discharge 8/9). Data on presenting EKG were available for 39/49 patients:
21/39 had documented ST-segment elevations, and 31/39 had documented ventricular tachycardia or ﬁbrillation. Interhospital transfers
accounted for 9/49 OHCA patients, with 8/9 surviving to discharge.
Therapeutic hypothermia was administered in 19/49 patients: survival
to discharge was 14/19 with hypothermia and 18/20 without
hypothermia.
By multivariable analysis, pre-MCS/PCI predictors of OHCA survival
included younger age, female sex, fewer diseased vessels, left anterior
descending (LAD) culprit, lower troponin, and higher lactate (Fig. 2).

Table 1
SCAI Shock Stages at the time of PCI for OHCA, IHCA, and no cardiac arrest cohorts. Due to
rounding, percentages may not add up to 100%.
SCAI Shock Stage at PCI
C
OHCA
IHCA
No cardiac arrest

n (%) 27 (59%)
n (%) 23 (37%)
n (%) 18 (78%)

D

E

0 (0%)
4 (6%)
2 (9%)

19 (41%)
35 (56%)
3 (13%)

n (%) of total cohort
with SCAI Shock Data
available
46/49 (94%)
62/69 (90%)
23/149 (15%)
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Fig. 2. Pre-MCS/PCI predictors of OHCA survival included younger age, female sex, fewer diseased vessels, left anterior descending (LAD) culprit, lower troponin, and higher lactate.

occurred. Consistent with this explanation, the SCAI Shock Stage at the
time of PCI was indeed highest for the IHCA group, intermediate for
the OHCA group, and lowest for the group without cardiac arrest, although statistical signiﬁcance was not achieved.
Not surprisingly, we found that OHCA patients with better
baseline health were more likely to survive. Younger age, fewer diseased vessels, and lower troponin were associated with survival. An
LAD culprit for ACS with CGS may also be prognostically favorable:
because the LAD typically supplies around 50% of the myocardium,
an LAD lesion alone can cause CGS, whereas a patient with CGS and
a non-LAD culprit is likely to have other signiﬁcant coronary disease,
allowing a non-LAD culprit to cause CGS. The interpretation of a
slightly higher initial lactate in survivors could relate to more acute
shock in these patients from sudden occlusion of a single major coronary artery as opposed to better compensated shock in patients
with diffuse, multi-vessel disease. Acute dysfunction of an otherwise
healthy heart may be easier to reverse than more insidious pathology, and the relative contributions of reperfusion and MCS to survival cannot be separated in this study.
Counterintuitively, we observed that door to support, shock to support, and door to balloon times were higher among survivors than nonsurvivors. The ﬁnding of greater survival despite delayed care suggests
an underlying propensity of these patients to survive, perhaps related
to their younger age, fewer disease vessels, and lower troponin levels.
This highlights the critical importance of research to deﬁne precisely
the population of CGS and OHCA patients likely to beneﬁt from MCS.
That survivors received slower care than non-survivors emphasizes
that patient selection may be the important predictor of survival. Of
note, this observation runs contrary to a pre-MCS era study of patients
with witnessed arrest that reported 74% survival if ﬁrst deﬁbrillation
was administered within 3 min and 49% survival if deﬁbrillation was
ﬁrst administered after more than 3 min [9].
Post-procedurally, we again found that OHCA patients with better
health status were more likely to survive. Complete revascularization
in conjunction with fewer vessels treated, higher CPO, and fewer vasopressors/inotropes were associated with increased survival.
Despite the evidence and guidelines, rates of coronary angiography
and subsequent PCI in OHCA patients are low. Among the 407,974

4. Discussion
In our study of 49 NCSI patients presenting with OHCA, we report a
high rate of 85.7% survival to discharge. While this high survival rate
may not be generalizable to all OHCA patients, the key implication of
the study is that, within a population of patients with CGS treated
with MCS, excellent outcomes can be achieved in an appropriately selected subset of OHCA patients. Among these patients, utilization of
MCS within a streamlined, protocolized approach to CGS may contribute to survival.
First, OHCA patients were more likely to survive to discharge than
IHCA patients. The fact that enrolled OHCA patients had survived long
enough to reach a hospital and undergo MCS and PCI selects for a
survival-prone population within the population of all OHCA victims.
Conversely, enrolled IHCA patients may be sicker and more prone not
to survive, but they reach the catheterization laboratory and are enrolled simply because they were in the hospital when their arrests

Fig. 3. Survivors actually had delayed MCS and PCI compared to non-survivors.
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Fig. 4. MCS/PCI predictors of survival included fewer vessels treated, complete revascularization, higher post-Impella cardiac power output, and few inotropes.

5. Strengths and limitations

patients in the Nationwide Inpatient Sample (NIS) hospitalized with
out-of-hospital ventricular tachycardia or ﬁbrillation from 2000 to
2012, only 35% underwent coronary angiography [10]. This rate is extremely low given that a culprit vessel may be identiﬁed in 80.2% of patients with STEMI but also in 33.2% of patients without ST-segment
elevation [11]. The current study suggests that coronary angiography,
MCS, and PCI may be associated with increased OHCA survival when applied to appropriately selected patients. Again, patient selection is critical: The Coronary Angiography after Cardiac Arrest (COACT) study of
552 patients without ST-segment elevation found no difference in survival between patients undergoing early or delayed angiography [12].
The Cardiac Arrest Hospital Prognosis (CAHP) score identiﬁes the likelihood of survival to discharge based upon presentation characteristics:
age, shockable rhythm, time from collapse to CPR, time from CPR to return of spontaneous circulation, location of cardiac arrest, epinephrine
dose, and arterial pH [13]. Now, our work has identiﬁed additional
prognostically-valuable demographic, anatomic, and health status characteristics associated with such patients who may beneﬁt from MCS and
are more likely to survive to discharge.
More broadly, the in-hospital mortality rate associated with acute
MI complicated by cardiogenic shock has remained unchanged for 3 decades despite signiﬁcant advances in cardiovascular care. In 1988, early
in the era of emergent coronary angioplasty, Lee et al. reported 50%
mortality at 30 days following acute MI complicated by cardiogenic
shock treated with coronary angioplasty [14]. In 1999, in a similar patient population, the SHOCK (Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock) trial showed a similar 30-day
mortality of 46.7% for patients treated with revascularization (angioplasty or bypass surgery) and 56.0% for patients treated medically
(p = 0.11). As recently as 2016, Ouweneel found a similar 30-day mortality rate of 46% in patients treated with MCS following PCI [15]. Therefore, the NCSI paradigm of immediate MCS, with its initial report of only
28% in-hospital mortality [6], has the potential to save thousands of lives
if applied to the appropriate patients. Within the population of CGS patients, OHCA patients may derive particular beneﬁt from immediate
MCS given their propensity to delays in care. This paradigm must be explored further in cardiac arrest patients as suggested by the present
study.

Studies of OHCA are notoriously difﬁcult to conduct due to the challenges of obtaining informed consent and collecting data in an emergent
setting. NCSI represents a paradigm shift in the management of such patients: the standard of care at participating institutions is benchmarked
to the NCSI protocol, and consent from patients or family members must
only be obtained after the fact to allow inclusion of protected health information in the NCSI registry. Thus, the present study represents one of
the most extensive prospective analyses of OHCA patients treated with
MCS to date.
However, the NCSI study population is still quite small. Therefore,
many of these preliminary observations did not achieve statistical signiﬁcance. NCSI data collection continues, and with expanded NCSI enrollment, these observations can be evaluated further.
Furthermore, due to the pace of emergent care for OHCA patients,
data about patient history, bystander CPR, and pre-procedure laboratory and EKG ﬁndings could not always be collected reliably. These factors are major determinants of outcomes after OHCA. The present
ﬁndings are therefore only hypothesis-generating regarding predictors
of survival following OHCA treated with MCS and PCI and appropriate
patient selection for these procedures. The International Liaison Committee on Resuscitation has recommended a detailed reporting template for OHCA, emphasizing documentation of bystander witnesses,
dispatcher-assisted CPR, automated external deﬁbrillators, and shockable rhythms [16]. For future studies, we have begun to develop an interdisciplinary partnership with our emergency services colleagues to
implement this template for data collection, systematically recording
data immediately in the hospital emergency department instead of
performing retrospective reviews later in the hospital course.
Indeed, we fully acknowledge the major limitation of selection bias.
However, in the context of OHCA, selection bias can be viewed conversely as guidance for appropriate selection of OHCA patients most
likely to beneﬁt from treatment with an NCSI-style protocol. Accordingly, the study results may not be generalizable to all OHCA patients.
Furthermore, given the baseline characteristics of the OHCA survivors
studied and the fact that all NCSI subjects were treated with MCS, the
precise contribution of MCS to OHCA survival cannot be quantiﬁed.
4
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[4] Dumas F, et al. Emergency percutaneous coronary intervention in post-cardiac arrest
patients without ST-segment elevation pattern: insights from the PROCAT II Registry. JACC Cardiovasc Interv. 2016;9(10):1011–8.
[5] Callaway CW, et al. Part 8: post-cardiac arrest care: 2015 American Heart Association
guidelines update for cardiopulmonary resuscitation and emergency cardiovascular
care. Circulation. 2015;132(18 Suppl 2):S465–82.
[6] Basir MB, et al. Improved outcomes associated with the use of shock protocols: updates from the National Cardiogenic Shock Initiative. Catheter Cardiovasc Interv.
2019;93(7):1173–83.
[7] Basir MB, et al. Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: the Detroit cardiogenic shock initiative. Catheter Cardiovasc Interv. 2018;91(3):454–61.
[8] Baran D, et al. SCAI clinical expert consensus statement on the classiﬁcation of cardiogenic shock: This document was endorsed by the American College of Cardiology
(ACC), the American Heart Association (AHA), the Society of Critical Care Medicine
(SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter
Cardiovasc Interv. 2019;94(1).
[9] Valenzuela TD, et al. Outcomes of rapid deﬁbrillation by security ofﬁcers after cardiac arrest in casinos. N Engl J Med. 2000;343(17):1206–9.
[10] Patel N, et al. Trends and outcomes of coronary angiography and percutaneous coronary intervention after out-of-hospital cardiac arrest associated with ventricular ﬁbrillation or pulseless ventricular tachycardia. JAMA Cardiol. 2016;1(8):890–9.
[11] Kern KB, et al. Outcomes of comatose cardiac arrest survivors with and without STsegment elevation myocardial infarction: importance of coronary angiography. JACC
Cardiovasc Interv. 2015;8(8):1031–40.
[12] Lemkes JS, et al. Coronary angiography after cardiac arrest without ST-segment elevation. N Engl J Med. 2019;380(15):1397–407.
[13] Maupain C, et al. The CAHP (Cardiac Arrest Hospital Prognosis) score: a tool for risk
stratiﬁcation after out-of-hospital cardiac arrest. Eur Heart J. 2016;37(42):3222–8.
[14] Lee L, et al. Percutaneous transluminal coronary angioplasty improves survival in
acute myocardial infarction complicated by cardiogenic shock. Circulation. 1988;
78(6):1345–51.
[15] Ouweneel D, et al. Percutaneous mechanical circulatory support versus intra-aortic
balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll
Cardiol. 2017;69(3).
[16] Perkins GD, et al. Cardiac arrest and cardiopulmonary resuscitation outcome reports:
update of the Utstein Resuscitation Registry Templates for Out-of-Hospital Cardiac
Arrest: a statement for healthcare professionals from a task force of the International
Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian and New Zealand Council on Resuscitation, Heart and
Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa, Resuscitation Council of Asia); and the American Heart Association Emergency Cardiovascular Care Committee and the Council on
Cardiopulmonary, Critical Care, Perioperative and Resuscitation. Circulation. 2015;
132(13) (p. 1286-300).

6. Conclusion
This study is consistent with the hypothesis that, within a population
of patients with CGS treated with MCS, excellent outcomes may be
achieved even in those presenting with OHCA when appropriately selected by prognostic demographic, anatomic, and health status characteristics. A larger study population is needed to validate these
observations.
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